Vanda Pharmaceuticals Inc. VNDA was a big mover last session, as the company saw its shares rise over 8% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent …
While Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) have appreciated 38 percent since the favorable U.S. Fanapt IP ruling on August 25, Jefferies’ Matthew J. Andrews believes that there could be potential for long-term upside to the …
After a surprise FDA approval for Fanapt (iloperidone) for second-line schizophrenia therapy in May 2009, Vanda Pharmaceuticals (NASDAQ:VNDA) stock rose nearly 800% and has traded in the $12-$15 range since then until mid …
Many investors like to look for momentum in stocks, but this can be very tough to define. There is great debate …
WASHINGTON (AP) _ Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported a loss of $604,000 in its fourth quarter. The Washington-based company said it had a loss of 1 cent per share. Earnings, adjusted for amortization …
Vanda Pharmaceuticals (VNDA) was a big mover last session, as its shares rose over 8% on the day. The upside was driven by the company’s second-quarter financial result announcement. This also led to far more shares changing …